Neurocrine Chief Commercial Officer Eric Benevich disposes of 2,154 common shares worth $333,428.94 - NBIX News | RalliesNeurocrine Chief Commercial Officer Eric Benevich disposes of 2,154 common shares worth $333,428.94
N
NBIX• Benevich reports share sale and option exercise
- Neurocrine Biosciences Chief Commercial Officer Eric Benevich sold 2,154 shares of common stock on Sept. 9, 2026 at $154.61.
- He exercised an incentive stock option for 3,194 shares the same day at $43.24.
- Holdings stood at 64,408 shares following the transactions.
•
